Mayukh Sukhatme Roivant Sciences Ltd. (ROIV) insider trading activity

Mayukh Sukhatme is Pres&Chief Investment Officer of Roivant Sciences Ltd.. Currently has a direct ownership of 18.8 Million shares of ROIV, which is worth approximately $210 Million. The most recent transaction as insider was on Dec 26, 2024, when has been sold 689,495 shares (Common Shares) at a price of $12.01 per share, resulting in proceeds of $8,280,834. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.8M

16.24% 3M change

472.69% 12M change

Total Value Held $210 Million

Mayukh Sukhatme Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 26 2024	SELL Open market or private sale	$8,280,834 $12.01 p/Share	689,495 Reduced 3.53%	18,836,547 Common Shares
Dec 26 2024	BUY Exercise of conversion of derivative security	$2,654,555 $3.85 p/Share	689,495 Added 3.41%	19,526,042 Common Shares
Dec 24 2024	SELL Open market or private sale	$2,231,352 $12.0 p/Share	185,946 Reduced 0.98%	18,836,547 Common Shares
Dec 24 2024	BUY Exercise of conversion of derivative security	$715,892 $3.85 p/Share	185,946 Added 0.97%	19,022,493 Common Shares
Dec 23 2024	SELL Open market or private sale	$129,552 $12.0 p/Share	10,796 Reduced 0.06%	18,836,547 Common Shares
Dec 23 2024	BUY Exercise of conversion of derivative security	$41,564 $3.85 p/Share	10,796 Added 0.06%	18,847,343 Common Shares
Dec 18 2024	SELL Open market or private sale	$4,971,637 $12.05 p/Share	412,584 Reduced 2.14%	18,836,547 Common Shares
Dec 18 2024	BUY Exercise of conversion of derivative security	$1,588,448 $3.85 p/Share	412,584 Added 2.1%	19,249,131 Common Shares
Dec 03 2024	SELL Other acquisition or disposition	$44,590,736 $12.21 p/Share	3,651,985 Reduced 16.24%	18,836,547 Common Shares
Jul 26 2024	BUY Grant, award, or other acquisition	-	18,836,547 Added 45.58%	22,488,532 Common Shares
Mar 30 2024	SELL Payment of exercise price or tax liability	$3,859,863 $10.54 p/Share	366,211 Reduced 9.11%	3,651,985 Common Shares
Mar 30 2024	BUY Exercise of conversion of derivative security	-	729,081 Added 15.36%	4,018,196 Common Shares
Dec 27 2023	BUY Exercise of conversion of derivative security	-	71,365 Added 2.12%	3,289,115 Common Shares
Sep 27 2023	BUY Exercise of conversion of derivative security	-	27,790 Added 0.86%	3,217,750 Common Shares
Aug 27 2023	BUY Exercise of conversion of derivative security	-	22,565 Added 0.7%	3,189,960 Common Shares
Jul 27 2023	BUY Exercise of conversion of derivative security	-	43,212 Added 1.35%	3,167,395 Common Shares
May 27 2023	BUY Exercise of conversion of derivative security	-	99,458 Added 3.09%	3,124,183 Common Shares

Mayukh Sukhatme

Pres&Chief Investment Officer

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Value

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV

Account